Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bonadonna G., Rossi A., Valagussa P., Banfi A., Veronesi U. The CMF program for operable breast cancer with positive axillary nodes. Updated analysis on the disease-free interval, site of relapse and drug tolerance. Cancer. 1977 Jun;39(6 Suppl):2904–2915. doi: 10.1002/1097-0142(197706)39:6<2904::aid-cncr2820390677>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
- Fisher B., Glass A., Redmond C., Fisher E. R., Barton B., Such E., Carbone P., Economou S., Foster R., Frelick R. L-phenylalanine mustard (L-PAM) in the management of primary breast cancer. An update of earlier findings and a comparison with those utilizing L-PAM plus 5-fluorouracil (5-FU). Cancer. 1977 Jun;39(6 Suppl):2883–2903. doi: 10.1002/1097-0142(197706)39:6<2883::aid-cncr2820390676>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
- Kiang D. T., Frenning D. H., Goldman A. I., Ascensao V. F., Kennedy B. J. Estrogen receptors and responses to chemotherapy and hormonal therapy in advanced breast cancer. N Engl J Med. 1978 Dec 14;299(24):1330–1334. doi: 10.1056/NEJM197812142992403. [DOI] [PubMed] [Google Scholar]
- Lippman M. E., Allegra J. C., Thompson E. B., Simon R., Barlock A., Green L., Huff K. K., Do H. M., Aitken S. C., Warren R. The relation between estrogen receptors and response rate to cytotoxic chemotherapy in metastatic breast cancer. N Engl J Med. 1978 Jun 1;298(22):1223–1228. doi: 10.1056/NEJM197806012982203. [DOI] [PubMed] [Google Scholar]
- Manni A., Trujillo J. E., Marshall J. S., Brodkey J., Pearson O. H. Antihormone treatment of stage IV breast cancer. Cancer. 1979 Feb;43(2):444–450. doi: 10.1002/1097-0142(197902)43:2<444::aid-cncr2820430207>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
- McGuire W. L. Hormone receptors: their role in predicting prognosis and response to endocrine therapy. Semin Oncol. 1978 Dec;5(4):428–433. [PubMed] [Google Scholar]
- McGuire W. L., Horwitz K. B., Pearson O. H., Segaloff A. Current status of estrogen and progesterone receptors in breast cancer. Cancer. 1977 Jun;39(6 Suppl):2934–2947. doi: 10.1002/1097-0142(197706)39:6<2934::aid-cncr2820390680>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
- Moore F. D., VanDevanter S. B., Boyden C. M., Lokich J., Wilson R. E. Adrenalectomy with chemotherapy in the treatment of advanced breast cancer: objective and subjective response rates; duration and quality of life. Surgery. 1974 Sep;76(3):376–390. [PubMed] [Google Scholar]
- Santen R. J., Samojlik E., Lipton A., Harvey H., Ruby E. B., Wells S. A., Kendall J. Kinetic, hormonal and clinical studies with aminoglutethimide in breast cancer. Cancer. 1977 Jun;39(6 Suppl):2948–2958. doi: 10.1002/1097-0142(197706)39:6<2948::aid-cncr2820390681>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]